申请人:The Procter & Gamble Company
公开号:US05824661A1
公开(公告)日:1998-10-20
Compounds of the formula ##STR1## where m and n are integers 0 to 10 and m+n equals 0 to 10, (a) X is O or S (b) Z is a covalent bond; a monocyclic or polycyclic carbocycle ring moiety; or a monocyclic or polycyclic heterocyclic ring moiety containing one or more heteroatoms selected from O, S, or N; (c) Q is covalent bond; O; or S; (d) R is COOH, SO.sub.3 H, PO.sub.3 H.sub.2, or P(O)(OH)R.sup.4, wherein R.sup.4 is C.sub.1 -C.sub.8 alkyl; (e) R.sup.1, R.sup.2 and R.sup.5 are as defined in the claims. are useful in the treatment of calcium and phosphate elated disorders, such as arthritis and the like.
式为##STR1##的化合物,其中m和n是0到10的整数,且m+n等于0到10,(a) X为O或S,(b) Z为共价键;单环或多环碳环环基;或含有一个或多个杂原子(O、S或N)的单环或多环杂环环基;(c) Q为共价键;O;或S;(d) R为COOH、SO.sub.3 H、PO.sub.3 H.sub.2或P(O)(OH)R.sup.4,其中R.sup.4为C.sub.1-C.sub.8烷基;(e) R.sup.1、R.sup.2和R.sup.5如权利要求所定义。这些化合物在治疗钙和磷相关疾病,如关节炎等方面有用。